The SYNBIOTECH R&D team has brought together technical consultants and research talents from multiple biological domains and imported many novel R&D platforms such as the bacterial strain identification platform, cellular immunomodulation platform, anti-oxidant evaluation platform, pathogenic bacteria inhibition platform, and others. The team also developed the core technology of SYNTEK™ thorough culture optimization system to further improve the technological threshold, and breadth and depth of applications of lactic acid bacteria. Through close collaboration of production with management, in combination with global patent layout, continuous research and cumulation of R&D capabilities, expanding of R&D facilities and academic research, investment in manpower and capital, and continuous innovation in raw materials, production process, and service model, our team will conform to the changes in market trends and fulfill customers’ requirements.